TAK-242

DRUG2 trials

Sponsors

Akaza Bioscience Ltd, Yaqrit Ltd

Conditions

Acute-On-Chronic Liver FailureAlcoholic HepatitisLiver Cirrhosis, Alcoholic

Phase 2

TAK-242 in Patients With Acute Alcoholic Hepatitis

Akaza Bioscience LtdAcute-On-Chronic Liver Failure

Start: 2021-12-31End: 2022-12-31Target: 100Updated: 2021-08-02

A-TANGO Phase 2 Study

Not yet recruitingNCT06890039

Yaqrit LtdAcute-On-Chronic Liver Failure, Alcoholic Hepatitis, Liver Cirrhosis, Alcoholic

Start: 2025-09-01End: 2026-12-31Target: 78Updated: 2025-07-29